REFERENCES

1. Murphy R. Training in the diagnosis and management of vulvovaginal diseases. J Reprod Med 2007;52:87-92.

2. Nunns D, Mandal D. The chronically symptomatic vulva: preva­lence in primary health care.

3. Harlow BL, Wise LA, Stewart EG. Prevalence and predictors of chronic lower genital tract discomfort. Am J Obstet Gynecol 2001;185:545-50.

4. Hickey S, Bell H. Quality of life in the vulvar clinic: a pilot study. J Low Genit Tract Dis 2010;14:225-29.

5. Sargeant HA, O’Callaghan FV The impact of chronic vulval pain on quality of life and psychosocial well-being. Aust N Z J Obstet Gynaecol 2007;47:235-39.

6. Coulson C, Crowley T. Current thoughts on psychosexual dis­orders in women. Obstet Gynaecol 2007;9:217-22.

7. Bair E, Simmons E, Hartung J, Desia K, Maixner W, Zolnoun D. Natural history of comorbid orofacial pain among women with vestibulodynia. Clin JPain 2015;31:73-78.

8. McPherson T, Cooper S. Vulval lichen sclerosus and lichen planus. Dermatol Ther 2010;23:523-32

9. Nunns D, Mandal D, Byrne M, et al. British Society for the Study of Vulval Disease (BSSVD) Guideline Group. Guidelines for the management of vulvodynia. Br J Dermatol 2010;162:1180-85.

10. Margesson LJ. Overview of treatment of vulvovaginal disease. Skin Therapy Lett 2011;16:5-7.

11. Hampson JP, Reed BD, Clauw DJ, et al. Augmented central pain processing in vulvodynia. J Pain 2013;14:579-89.

12. Neill SM, Lewis FM, Tatnall FM, Cox NH. British Association of Dermatologists’ guidelines for the management of lichen sclerosus 2010. Br J Dermatol 2010;163:672-82.

13. Patel AN, Simpson RC, Cohen SN. In a patient with an immunobullous disorder, is transportation of the skin biopsy in normal saline adequate for direct immunofluorescence analysis? A critically appraised topic. Br J Dermatol 2013;169:6-10.

14.

15. O’Gorman SM, Torgerson RR Allergic contact dermatitis of the vulva. Contact Dermatitis 2013;24:64-72.

16. Wujanto L, Wakelin S. Allergic contact dermatitis to colophonium in a sanitary pad-an overlooked allergen? Contact Dermatitis 2012;66:161-62.

17. National Institute for Health and Care Excellence (NICE). The Assessment and Management of Psoriasis. Clinical guideline [CG153], last updated September 2017. London: NICE; 2012. Available at: https://www.nice.org.uk/guidance/cg153.

18. Kirtschig G, Becker K, Gunthert A, et al. Evidence-based (S3) guideline on (anogenital) lichen sclerosus. J Eur Acad Dermatol Venereol 2015;29:e1-43.

19. Cheng S, Kirtschig G, Cooper S, Thornhill M, Leonardi-Bee J, Murphy R. Interventions for erosive lichen planus affecting mu­cosal sites. Cochrane Database Syst Rev 2012;2:CD008092.

20. Chi CC, Kirtschig G, Baldo M, Brackenbury F, Lewis F, Wojnarowska F. Topical interventions for genital lichen sclerosus. Cochrane Database Syst Rev 2011;12:CD008240.

21. Bradford J, Fischer G. Long-term management of vulval lichen sclerosus in adult women. AustNZJ ObstetGynaecol 2010;50:148-52.

22. Simpson RC, Littlewood SM, Cooper SM, et al. Real-life experience of managing vulval erosive lichen planus: a case-based review and U.K. multicentre case note audit. Br J Dermatol 2012;167:85-91.

23. Simpson RC, Murphy R. Is vulval erosive lichen planus a prema- lignant condition? Arch Dermatol 2012;148:1314-16.

24. Simpson RC, Thomas KS, Murphy R. Outcome measures for vulval skin conditions: a systematic review of randomized con­trolled trials. Br JDermatol 2013;169:494-501.

25. Cooper SM, Wojnarowska F. Influence of treatment of ero­sive lichen planus of the vulva on its prognosis. Arch Dermatol 2006;142:289-94.

26. Farage MA, Miller KW, Ledger WJ. Determining the cause of vulvovaginal symptoms.

27. Carstens E, Jinks SL. Skin cooling attenuates rat dorsal horn neuronal responses to intracutaneous histamine. Neuroreport 1998;9:4145-49.

28. Thaςi D, Salgo R. Malignancy concerns of topical calcineurin inhibitors for atopic dermatitis: facts and controversies. Clin Dermatol 2010;28:52-56.

29. Green C, Colquitt JL, Kirby J, Davidson P. Topical corticosteroids for atopic eczema: clinical and cost effectiveness of once-daily vs. more frequent use. Br J Dermatol 2005;152:130-41.

30. Berth- Jones J, Damstra RJ, Golsch S, et al. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, par­allel group study. BMJ 2003;326:1367.

31. Cheung ST, Gach JE, Lewis FM. A retrospective study of the re­ferral patterns to a vulval clinic: highlighting educational needs in this subspecialty. J Obstet Gynaecol 2006;26:435-37.

32. Haefner HK. Report of the International Society for the Study of Vulvovaginal Disease terminology and classification of vulvodynia. J Low Genit Tract Dis 2007;11:48-49.

33. Pink L, Rancourt V, Gordon A. Persistent genital arousal in women with pelvic and genital pain. J Obstet Gynaecol Can 2014;36:324-30.

34. Peckham BM, Mak DG, Patterson JJ. Focal vulvitis: a character­istic syndrome and a cause of dyspareunia. Am J Obstet Gynecol 1986;154:855-64.

35. Marinnoff SC, Turner MLC. Vulvar vestibulitis syndrome: an overview. Am J Obstet Gynecol 1991;165:1228-33.

36. Nunns D, Mandal D. Psychological and psychosexual aspects of vulval vestibulitis. Genitourin Med 1997;73:541-44.

37. Rosen NO, Muise A, Bergeron S, Impett EA, Boudreau GK. Approach and avoidance sexual goals in couples with provoked vestibulodynia: associations with sexual, relational, and psycho­logical well-being. J Sex Med 2015;12:1781-90.

38. Leo RJ, Dewani S. A systematic review of the utility of antidepres­sant pharmacotherapy in the treatment of vulvodynia pain. J Sex Med 2013;10:2497-505.

39. Goldfinger C, Pukall CF, Thibault-Gagnon S, McLean L, Chamberlain S. Effectiveness of cognitive-behavioral therapy and physical therapy for provoked vestibulodynia: a randomized pilot study. J Sex Med 2016;13:88-94.

40. Masheb RM, Kerns RD, Lozano C, et al. A randomized clinical trial for women with vulvodynia: cognitive behavioral therapy vs. supportive psychotherapy. Pain 2009;141:31-40.

41. Eva LJ, Narain S, Orakwue CO, Luesley DM. Is modified vestibulectomy for localized provoked vulvodynia an ef­fective long-term treatment? A follow-up study. J Reprod Med 2008;53:435-440.

42. Bergeron S, Bionic YM, Khalife S, et al. A randomised com­parison of group cognitive-behavioural therapy, surface electromyographic biofeedback and vestibulectomy in the treat­ment of dyspareunia resulting from vulvar vestibulitis. Pain 2001;91:297-306.